Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Seres Therapeutics, Inc. | 100,000 | reported | 10 Apr 2025 | tx 10+374,746 |
| BIOMARIN PHARMACEUTICAL INC | 38,950 | reported | 20 May 2025 | tx 15+69,700−4,430 |
| Metagenomi Therapeutics, Inc. | 21,000 | reported | 10 Jun 2025 | tx 2+99,636 |
| MPM ACQUISITION CORP | 1,895 | reported | 15 Aug 2022 | tx 23+227,900−41,600 |
| Mersana Therapeutics, Inc. | 0 | reported | 06 Jan 2026 | tx 30+339,158−13,563 |
| TRANZYME INC | 0 | reported | 11 Dec 2017 | tx 4+32,500−32,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Jan 2026 | TENDER | Mersana Therapeutics, Inc. | 1,567 | — | |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 2,460 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 800 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 544 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,000 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 450 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 368 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 125 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,002 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 513 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,800 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 734 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 2,200 | — | deriv |
| 12 Jun 2025 | GRANT_AWARD | Mersana Therapeutics, Inc. | 61,500 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 21,000 | 0.00 USD | deriv |
| 20 May 2025 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 6,650 | 0.00 USD | |
| 10 Apr 2025 | GRANT_AWARD | Seres Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | Mersana Therapeutics, Inc. | 55,000 | 0.00 USD | deriv |
| 21 May 2024 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 4,720 | 0.00 USD | |
| 04 Apr 2024 | GRANT_AWARD | Seres Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 01 Apr 2024 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 78,636 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Mersana Therapeutics, Inc. | 6,112 | 0.00 USD | |
| 02 Oct 2023 | GRANT_AWARD | Mersana Therapeutics, Inc. | 11,011 | 0.00 USD | |
| 03 Jul 2023 | GRANT_AWARD | Mersana Therapeutics, Inc. | 4,217 | 0.00 USD | |
| 22 Jun 2023 | GRANT_AWARD | Seres Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |